1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 04 JANUARY 2016

Cancer Drug News 04 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - 2016 Global Oncology Pipeline To Benefit From Breaking Innovation Barriers
Industry Trend Analysis - Adcetris To Maintain Lymphoma Market Position
Industry Brief - EMA Validates Qinprezo MAA For r/r AML
Industry Brief - Sun Gains US Imatinib Approval
Industry Brief - Revlimid Granted Japanese Expanded Approval In Multiple Myeloma
Industry Brief - OXiGENE's OXi4503 Gains EU Orphan Designation For AML
Industry Brief - Foundation Medicine/Mirati To Co-Develop Glesatinib Companion Diagnostic
Industry Brief - Merrimack Amends MM-121 Phase II NSCLC Study
Industry Brief - BI's 3rd-Generation EGFR TKI Receives Breakthrough Designation In Lung Cancer
Industry Brief - Tagrisso In NSCLC Subpopulation Recommended For EC Approval
Industry Brief - Opdivo Approved For NSCLC In Japan
Industry Brief - Exelixis Completes NDA Submission For Cabozantinib In RCC
Industry Brief - AVEO/EUSA Sign Tivozanib Licensing Deal In Europe
Industry Brief - Merck/Pfizer Advance Avelumab Development
Industry Brief - Janssen Inks Cancer-Focused Pact With Bavarian Nordic
Industry Brief - Merck/Pfizer/Syndax Collaborate On Avelumab/Entinostat Combination In OC
Industry Brief - FDA Approves Expanded Indication Keytruda In Melanoma
Industry Brief - EC Approves Amgen's Imlygic As First Oncolytic Immunotherapy
Industry Brief - Array's Binimetinib Phase III Trial Meets Primary Endpoint For NRAS-Mutant Melanoma
Industry Brief - Agenus Acquires PhosImmune
Industry Brief - Sunshine Acquires All Remaining Worldwide Patents For Adva-27a
Industry Brief - Celgene Settles Lenalidomide Patent Litigation
Industry Trend Analysis - Rising Cancer Prevalence To Buoy Pharmaceutical Demand
Industry Brief - Cellectar/Pierre Sign Oncology Research Collaboration
Industry Brief - BI Invests In Biopharmaceutical Production Facility In Vienna
Industry Brief - Merrimack Raises Funds Through Private Placement
Industry Brief - Amgen Acquires Medigene Spin-Off
Industry Brief - AstraZeneca Invests In Novel Cancer Opportunity
Industry Brief - Cancer Conferences - March 2016

Table Of Contents

Cancer Drug News 04 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Prescription barriers hurt 5 of the 9 brands we surveyed. Is your brand losing market share? In the EU5, one of the most prescribed NSCLC drugs is stuck in 2nd place due to the biggest barrier-related ...

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

7 of the 10 brands we surveyed lose share due to market barriers. Is your brand one of them? In the US, market barriers are causing 7 of the 10 NSCLC drugs we surveyed to lose market share. What’s ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.